This strongly suggests that IDO induction may play an important role in COVID-19 patients, as suggested in Figure 3 here, especially in those with severe symptoms requiring intensive care, and, by inference, IDO-dependent production of proinflammatory Kyn metabolites may be a vital component of the pathophysiology of this viral infection. This evidence concerns the gene IDO1 and COVID-19.